| http://www.w3.org/ns/prov#value | - But because quinidine is so cheap - as low as a quarter per pill - and only indicated for a very small group of heart patients, drug companies have little incentive to go through the regulatory hurdles to market it, researchers said.it is a problem for a small number of patients worldwide, but it is a very serious problem because they have no other alternatives, said Dr. Sami Viskin, a cardiologis
|
